Device Dental Implant

Nobelactive

Payments companies reported to CMS as associated with Nobelactive. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1.2Massociated payments (2023-2025)

15,051clinicians with associated payments

5companies reporting

By year

2023 $1.2M

2024 $5,168

2025 $929

Payments reported as associated with Nobelactive, per program year, as reported to CMS.

Who makes it

Specialties most often involved

General Practice (Dentist) $379K

Dentist $316K

Orthodontics and Dentofacial Orthopedics $228K

Oral and Maxillofacial Surgery $138K

Periodontics $73K

Prosthodontics $37K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Nobelactive

These are the largest totals companies reported as associated with Nobelactive. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Donald Liberty	El Dorado Hills, CA	Oral and Maxillofacial Surgery	$4,222.91
Steven Reff	Westfield, NJ	General Practice (Dentist)	$1,809.99
Jedediah Huss	Thousand Oaks, CA	Dentist	$1,809.07
Timothy Betita	Dana Point, CA	Oral and Maxillofacial Surgery	$1,650.09
Eric Baker	Dana Point, CA	Oral & Maxillofacial Surgery	$1,620.05
James Michino	Honolulu, HI	Oral and Maxillofacial Surgery	$1,566.09
Sebastian East	Dana Point, CA	Oral and Maxillofacial Surgery	$1,543.83
Brian Chisdak	Bozeman, MT	Oral & Maxillofacial Surgery	$1,541.01
William Dischinger	Lake Oswego, OR	Orthodontics and Dentofacial Orthopedics	$1,467.43
Navneet Arora	Rochester, NY	Periodontics	$1,398.21

Prescribed Nobelactive?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.